title: A pilot study to evaluate the vascular endothelial growth factor receptor tyrosine kinase inhibitor AZD2171 and chemotherapy in locally advanced and inflammatory breast cancer.
authors.affiliation: Breast Cancer Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
authors.forename: Neelima
authors.initials: N
authors.lastname: Denduluri
authors.forename: Antoinette R
authors.initials: AR
authors.lastname: Tan
authors.forename: Janice
authors.initials: J
authors.lastname: Walshe
authors.forename: Arlene
authors.initials: A
authors.lastname: Berman
authors.forename: Sherry X
authors.initials: SX
authors.lastname: Yang
authors.forename: Catherine K
authors.initials: CK
authors.lastname: Chow
authors.forename: Sandra M
authors.initials: SM
authors.lastname: Swain
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000209:etiology; D017322:Clinical Trials, Phase II as Topic; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D010865:Pilot Projects; D011799:Quinazolines / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors*; D007211:Indoles
chemical_list: D004791:Enzyme Inhibitors; D011799:Quinazolines; D040262:Receptors, Vascular Endothelial Growth Factor; C500926:cediranib; D007211:Indoles